Herbst Suzi R
Known title: Chief Operating OfficerCIK: 0001672162
Herbst Suzi R's purchase track record
Herbst Suzi R has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/12/2022 | VATE | $750 | -53.1% | -81.3% | -18.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| VATE | ▼ Sell | Tax Withholding | 8,060 | $24K | 3/15/2023 | View on chart |
| VATE | ▲ Buy | Grant | 85,324 | $0 | 3/15/2023 | View on chart |
| VATE | ▼ Sell | Tax Withholding | 9,381 | $28K | 3/13/2023 | View on chart |
| VATE | ▼ Sell | Open Market | 5,184 | $20K | 4/20/2022 | View on chart |
| VATE | ▲ Buy | Open Market | 200 | $750 | 4/12/2022 | View on chart |
| VATE | ▼ Sell | Open Market | 8,081 | $29K | 3/16/2022 | View on chart |
| VATE | ▲ Buy | Grant | 69,832 | $0 | 3/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Innovate Corp. highlighted in Zacks analyst blog
Innovate Corp. (VATE) was included in a recent Zacks analyst blog that also featured AMD, Linde and Amgen. The mention places the company among a group of well‑known peers, potentially drawing investor attention. The stock currently carries a dividend yield of 9.62% and trades within a 52‑week range of $3.75 to $21.30.
Innovate Corp. highlighted in Zacks analyst blog. Innovate Corp. (VATE) was included in a recent Zacks analyst blog that also featured AMD, Linde and Amgen. The mention places the company among a group of well‑known peers, potentially drawing investor attention. The stock currently carries a dividend yield of 9.62% and trades within a 52‑week range of $3.75 to $21.30.